CN1824224A - 'Coptis-amonum' sugar reducing compound ready prepared Chinese medicinal capsule - Google Patents
'Coptis-amonum' sugar reducing compound ready prepared Chinese medicinal capsule Download PDFInfo
- Publication number
- CN1824224A CN1824224A CN 200510049131 CN200510049131A CN1824224A CN 1824224 A CN1824224 A CN 1824224A CN 200510049131 CN200510049131 CN 200510049131 CN 200510049131 A CN200510049131 A CN 200510049131A CN 1824224 A CN1824224 A CN 1824224A
- Authority
- CN
- China
- Prior art keywords
- rhizoma coptidis
- fructus amomi
- chinese patent
- blood sugar
- sugar lowering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A hypoglycemic Chinese patent medicine in the form of capsules for the patients of diabetes is prepared from coptis root and amomum fruit through drying at 50-60 deg.C, grinding, mixing and loading in capsules.
Description
Technical field:
The present invention relates to the scheme of producing (prescription and preparation method thereof) of hypoglycemic pcm, especially relate to the few Chinese patent medicine of Chinese medicine ingredients and produce scheme.
Background technology:
Diabetes are the common chronic diseases of a kind of human endocrine system, at present, most in the world diabetes patients adopt the western medicine and medical practitioners theory and administrated method is treated, as everyone knows, take the Western medicine blood sugar lowering, instant effect, its mechanism of action are to promote to have the islets of langerhans of damage to increase its secretion of insulin amount; The side effect of taking for a long time behind the Western medicine is also big, and the result must cause: human body major organs such as liver, kidney are subjected to damage in various degree; At last, take the curative effect that various Western medicine also lose blood sugar lowering, enter the stage of regular insulin injection; And, take behind the Western medicine also very greatly to its dependency, in case the normal back drug withdrawal of blood glucose target, even keep the food-intake of hunger sensation, blood glucose target can rebound up in the same old way.
And the starting point that Chinese medicine is cured the disease is: effect a permanent cure (the maintenance islets of langerhans make it to restorative direction develop or/and the bio-identification password that Insulin receptor INSR in the active cell to a certain extent arranged to promote that glucose normally enters cell), be characterized in that treatment speed is slower, drug side effect is minimum, and medicine is not had dependency.Therefore, it is believed that:, should adopt the theoretical and administrated method of Chinese medicine and carry out long-term treatment and be only very wise move for the chronic disease of diabetes one class.But, to take to cut out at once behind the Chinese medicine and take Western medicine originally for a long time, blood glucose can rebound up immediately in the same old way.Have only and when finding diabetes, begin to take Chinese medicine.
Usually adopt the composition of treatment by Chinese herbs diabetes to tend to tens kinds of as many as, and even tens kinds, its mechanism of action is based on " wide spectrum ", owing to feel that the general curative effect dynamics of Chinese medicine is not enough, for this reason, at some Chinese medicine, for example: also suitably added western medicine composition in Chinese patent medicines such as " diabetes pilles ", this has just caused the worry that people take for a long time naturally again.
Summary of the invention:
The present invention's order: mainly be that a kind of curative effect of proposition is obvious, composition few and the extremely low hypoglycemic pcm capsule of cost is produced scheme.
To achieve these goals, intend adopting following technology:
Mainly be taken a kind of high curative effect based on Rhizoma Coptidis (cold), be the Chinese patent medicine capsule of only producing of assisting with Fructus Amomi (warm nature) by the powdery of two kinds of Chinese medicine ingredients, allow other think that the drug administration time and the difference of the present invention of a necessary complementary class open.
Main feature of the present invention: Chinese medicine ingredients few (only containing two flavors), cost extremely low (its market price can far below blood sugar lowering new product in the pure Chinese patent medicine on the market 1/10th), be a kind of Chinese patent drug that cures mainly the tangible non-wide spectrum purposes of diabetes curative effect.
The specific embodiment:
The present invention is made up of Rhizoma Coptidis and Fructus Amomi, and its manufacturing process comprises:
A. Rhizoma Coptidis and Fructus Amomi medicinal material drying are handled: its bake out temperature is between 50 to 60 ℃;
B. with exsiccant Rhizoma Coptidis and Fructus Amomi medical material grind into powder;
C. fill or mixing filling are made the Chinese patent medicine capsule in the glue,medicinal shell respectively with Rhizoma Coptidis and Fructus Amomi medicinal powder.
The cool stomach of Rhizoma Coptidis blood sugar lowering (curative effect is obvious), the kidney invigorating of Fructus Amomi stomach warming, the weight ratio of taking of Rhizoma Coptidis and Fructus Amomi is 5: 1～3, obey total amount Rhizoma Coptidis day and be no more than 5 grams, can be divided into 3 times takes, for the auxiliary medicaments of guaranteeing the glucose-lowering treatment emphasis, allow to prevent complication one class (if think to want), on Time of Administration, open (example: about a hour at interval) with difference of the present invention; When euglycemia continual and steady about half a year, can under the normal prerequisite of blood glucose, gradually reduce and take the Chinese medicine dose till discontinuing medication; After this, just can mainly be to rely on to allow the people in the dietary amount scope that does not feel hungry, control the blood glucose target of self.
When the present invention replaces the use of blood sugar lowering Western medicine, by using the transition period to form the Western medicine of can stopping using afterwards by following two:
A. transition period of taking simultaneously: be generally one month by the present invention and blood sugar lowering Western medicine.
B. transition period of taking simultaneously: at least one month by the present invention and decrement blood sugar lowering Western medicine.
Above-mentioned decrement blood sugar lowering Western medicine is meant that taking 1/2 or 1/3 (need increase by one month Chinese medicine Western medicine again this moment takes the transition period simultaneously) or 1/4 that the blood sugar lowering Western medicine reduces to original dose (increases by two months again ...); Take the diabetes patient of Western medicine for a long time, need to increase the above-mentioned transition period of taking Chinese medicine and Western medicine simultaneously; Take simultaneously at above-mentioned break-in transition period the blood sugar lowering Western medicine decrement determine with the blood glucose target of this transition period should: reach or be as the criterion near normal value.
Claims (4)
1. " Rhizoma Coptidis----Fructus Amomi " the compound Chinese patent medicine capsule of blood sugar lowering, it is characterized in that:
The Chinese medicine ingredients that adopts is made up of Rhizoma Coptidis and Fructus Amomi two flavors.
2. " Rhizoma Coptidis----as claimed in claim 1 Fructus Amomi " the compound Chinese patent medicine capsule of blood sugar lowering, it is characterized in that:
The described Chinese medicine ingredients of being made up of Rhizoma Coptidis and Fructus Amomi, the two the weight proportion of taking of front and back is 5: 1～3.
3. " Rhizoma Coptidis----as claimed in claim 1 Fructus Amomi " manufacturing process of the compound Chinese patent medicine capsule of blood sugar lowering, it is characterized in that it comprises the steps:
A. Rhizoma Coptidis and Fructus Amomi medicinal material drying are handled, its bake out temperature is between 50 to 60 ℃;
B. with exsiccant Rhizoma Coptidis and Fructus Amomi medical material grind into powder;
C. Rhizoma Coptidis and Fructus Amomi medicinal powder are filled to respectively and make the Chinese patent medicine capsule in the glue,medicinal shell, perhaps: Rhizoma Coptidis and Fructus Amomi medicinal powder mixing filling are made the Chinese patent medicine capsule in the glue,medicinal shell.
4. " Rhizoma Coptidis----as claimed in claim 1 Fructus Amomi " method that the compound Chinese patent medicine capsule of blood sugar lowering is replaced the blood sugar lowering Western medicine, it is characterized in that:
Needing with the moon is the excessive period that unit takes Chinese medicine and Western medicine simultaneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510049131 CN1824224A (en) | 2005-02-25 | 2005-02-25 | 'Coptis-amonum' sugar reducing compound ready prepared Chinese medicinal capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510049131 CN1824224A (en) | 2005-02-25 | 2005-02-25 | 'Coptis-amonum' sugar reducing compound ready prepared Chinese medicinal capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1824224A true CN1824224A (en) | 2006-08-30 |
Family
ID=36935169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510049131 Pending CN1824224A (en) | 2005-02-25 | 2005-02-25 | 'Coptis-amonum' sugar reducing compound ready prepared Chinese medicinal capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1824224A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100421714C (en) * | 2005-12-29 | 2008-10-01 | 颜怀伟 | Medicine and food dual purpose Chinese medicine for preventing and treating impotence and seminal emission and its manufacturing method |
| CN100435835C (en) * | 2005-12-29 | 2008-11-26 | 颜怀伟 | Medicine and food dual purpose Chinese medicinal health care product for preventing ane treating emission and its manufacturing method |
| CN100435837C (en) * | 2005-12-29 | 2008-11-26 | 颜怀伟 | Medicine and food dual purpose Chinese medicine for preventing and treating premature ejaculation and seminal emission and its manufacturing method |
| CN100435836C (en) * | 2005-12-29 | 2008-11-26 | 颜怀伟 | Medicine and food dual purpose Chinese medicine for preventing and treating impotence and premature ejaculation and its manufacturing method |
-
2005
- 2005-02-25 CN CN 200510049131 patent/CN1824224A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100421714C (en) * | 2005-12-29 | 2008-10-01 | 颜怀伟 | Medicine and food dual purpose Chinese medicine for preventing and treating impotence and seminal emission and its manufacturing method |
| CN100435835C (en) * | 2005-12-29 | 2008-11-26 | 颜怀伟 | Medicine and food dual purpose Chinese medicinal health care product for preventing ane treating emission and its manufacturing method |
| CN100435837C (en) * | 2005-12-29 | 2008-11-26 | 颜怀伟 | Medicine and food dual purpose Chinese medicine for preventing and treating premature ejaculation and seminal emission and its manufacturing method |
| CN100435836C (en) * | 2005-12-29 | 2008-11-26 | 颜怀伟 | Medicine and food dual purpose Chinese medicine for preventing and treating impotence and premature ejaculation and its manufacturing method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102271698B (en) | Pharmaceutical composition and use for preparing medicament thereof | |
| CN102273621A (en) | Food or health-care food for preventing and treating diabetes mellitus | |
| US6042834A (en) | Herbal composition for diabetes and method of treatment | |
| CN1824224A (en) | 'Coptis-amonum' sugar reducing compound ready prepared Chinese medicinal capsule | |
| CN103055176B (en) | Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof | |
| CN102940800A (en) | Traditional Chinese medicine for treating diabetes | |
| CN102631415B (en) | Traditional Chinese medicine composite as well as product and application thereof | |
| CN112843140B (en) | Medicine for treating thirst and conjunctival congestion caused by diabetes, preparation method and application | |
| CN101491605A (en) | Combination with blood sugar reducing function and preparation method thereof | |
| CN110613792B (en) | Traditional Chinese medicine composition with blood sugar reducing effect and preparation method and application thereof | |
| CN103181945B (en) | The purposes of Semen Luffae | |
| CN101537102A (en) | Medical and edible dual-purpose composition for treating sugar diabetes and preparation method thereof | |
| CN1927363A (en) | Health food, its preparation method and application | |
| CN104027450B (en) | A kind of Chinese medicine composition for the treatment of diabetes | |
| CN101745016B (en) | Extraction method of 'ginseng/radix ophiopogonis and schisandra chinensis' and preparation thereof | |
| CN115554345B (en) | A Chinese medicinal compound preparation for treating gout and hyperuricemia, and its preparation method | |
| CN104146255B (en) | A kind ofly be applicable to chewable tablets of type II diabetes people and preparation method thereof | |
| CN102716448A (en) | Chinese patent medicine and TCM decoction capable of effectively curing nausea and vomiting | |
| CN102000168B (en) | Medicament for reducing blood sugar | |
| CN107669860A (en) | A kind of Chinese medicine composition and its application with blood sugar reducing function | |
| CN101036714B (en) | Medicinal composition for treating and/or preventing diabetes | |
| CN101491584A (en) | Combination with blood sugar reducing function and preparation method thereof | |
| CN102225082A (en) | Medicament for preventing and treating diabetes and complications thereof and preparation method thereof | |
| CN101224256B (en) | Antidiabetics compounds of Chinese and western materia medica and preparing method thereof | |
| US10314876B2 (en) | Method for treating diabetes mellitus caused by pancreatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |